Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation

PHASE3TerminatedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Ischemia-Reperfusion Injury
Interventions
DRUG

nitric oxide for inhalation

Either 10 or 20 ppm of inhaled nitric oxide for 24 hour post transplant

DRUG

Placebo

Placebo gas will be given at 10 or 20 ppm for 24 hours post transplant

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mallinckrodt

INDUSTRY